Selected research
Industry Research
Non-Radioactive Nucleic Acid Labeling Industry Research Report 2026
Market perspective
The global Non-Radioactive Nucleic Acid Labeling market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Non-Radioactive Nucleic Acid Labeling is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Non-Radioactive Nucleic Acid Labeling is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Non-Radioactive Nucleic Acid Labeling is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Non-Radioactive Nucleic Acid Labeling include Thermo Fisher Scientific, Merck KGaA, Roche, Vector Labs, Promega, PerkinElmer, New England Biolabs, General Electric and Enzo Biochem, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Non-Radioactive Nucleic Acid Labeling market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Non-Radioactive Nucleic Acid Labeling Market by Company
Thermo Fisher Scientific
Merck KGaA
Roche
Vector Labs
Promega
PerkinElmer
New England Biolabs
General Electric
Enzo Biochem
Agilent Technologies
Non-Radioactive Nucleic Acid Labeling Segment by Type
DIG System
Biotin
Fluorescent
Others
Non-Radioactive Nucleic Acid Labeling Segment by Application
DNA Labeling
RNA Labeling
Oligonucleotide Labeling
Non-Radioactive Nucleic Acid Labeling Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Radioactive Nucleic Acid Labeling market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-Radioactive Nucleic Acid Labeling and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Radioactive Nucleic Acid Labeling.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Non-Radioactive Nucleic Acid Labeling manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Non-Radioactive Nucleic Acid Labeling by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Non-Radioactive Nucleic Acid Labeling in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DIG System
- Biotin
- Fluorescent
- Others
Applications
- DNA Labeling
- RNA Labeling
- Oligonucleotide Labeling
Companies covered
- Thermo Fisher Scientific
- Merck KGaA
- Roche
- Vector Labs
- Promega
- PerkinElmer
- New England Biolabs
- General Electric
- Enzo Biochem
- Agilent Technologies
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Non-Radioactive Nucleic Acid Labeling Market Size (2021-2032)
- 2.2.2 Global Non-Radioactive Nucleic Acid Labeling Sales (2021-2032)
- 2.2.3 Global Non-Radioactive Nucleic Acid Labeling Market Average Price (2021-2032)
- 2.3 Non-Radioactive Nucleic Acid Labeling by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 DIG System
- 2.3.3 Biotin
- 2.3.4 Fluorescent
- 2.3.5 Others
- 2.4 Non-Radioactive Nucleic Acid Labeling by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 DNA Labeling
- 2.4.3 RNA Labeling
- 2.4.4 Oligonucleotide Labeling
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Non-Radioactive Nucleic Acid Labeling Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Non-Radioactive Nucleic Acid Labeling Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Non-Radioactive Nucleic Acid Labeling Revenue of Manufacturers (2021-2026)
- 3.4 Global Non-Radioactive Nucleic Acid Labeling Average Price by Manufacturers (2021-2026)
- 3.5 Global Non-Radioactive Nucleic Acid Labeling Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Non-Radioactive Nucleic Acid Labeling, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Non-Radioactive Nucleic Acid Labeling, Product Type & Application
- 3.8 Global Manufacturers of Non-Radioactive Nucleic Acid Labeling, Established Date
- 3.9 Global Non-Radioactive Nucleic Acid Labeling Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Thermo Fisher Scientific
- 4.1.1 Thermo Fisher Scientific Company Information
- 4.1.2 Thermo Fisher Scientific Business Overview
- 4.1.3 Thermo Fisher Scientific Non-Radioactive Nucleic Acid Labeling Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Thermo Fisher Scientific Non-Radioactive Nucleic Acid Labeling Product Portfolio
- 4.1.5 Thermo Fisher Scientific Recent Developments
- 4.2 Merck KGaA
- 4.2.1 Merck KGaA Company Information
- 4.2.2 Merck KGaA Business Overview
- 4.2.3 Merck KGaA Non-Radioactive Nucleic Acid Labeling Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Merck KGaA Non-Radioactive Nucleic Acid Labeling Product Portfolio
- 4.2.5 Merck KGaA Recent Developments
- 4.3 Roche
- 4.3.1 Roche Company Information
- 4.3.2 Roche Business Overview
- 4.3.3 Roche Non-Radioactive Nucleic Acid Labeling Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Roche Non-Radioactive Nucleic Acid Labeling Product Portfolio
- 4.3.5 Roche Recent Developments
- 4.4 Vector Labs
- 4.4.1 Vector Labs Company Information
- 4.4.2 Vector Labs Business Overview
- 4.4.3 Vector Labs Non-Radioactive Nucleic Acid Labeling Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Vector Labs Non-Radioactive Nucleic Acid Labeling Product Portfolio
- 4.4.5 Vector Labs Recent Developments
- 4.5 Promega
- 4.5.1 Promega Company Information
- 4.5.2 Promega Business Overview
- 4.5.3 Promega Non-Radioactive Nucleic Acid Labeling Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Promega Non-Radioactive Nucleic Acid Labeling Product Portfolio
- 4.5.5 Promega Recent Developments
- 4.6 PerkinElmer
- 4.6.1 PerkinElmer Company Information
- 4.6.2 PerkinElmer Business Overview
- 4.6.3 PerkinElmer Non-Radioactive Nucleic Acid Labeling Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 PerkinElmer Non-Radioactive Nucleic Acid Labeling Product Portfolio
- 4.6.5 PerkinElmer Recent Developments
- 4.7 New England Biolabs
- 4.7.1 New England Biolabs Company Information
- 4.7.2 New England Biolabs Business Overview
- 4.7.3 New England Biolabs Non-Radioactive Nucleic Acid Labeling Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 New England Biolabs Non-Radioactive Nucleic Acid Labeling Product Portfolio
- 4.7.5 New England Biolabs Recent Developments
- 4.8 General Electric
- 4.8.1 General Electric Company Information
- 4.8.2 General Electric Business Overview
- 4.8.3 General Electric Non-Radioactive Nucleic Acid Labeling Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 General Electric Non-Radioactive Nucleic Acid Labeling Product Portfolio
- 4.8.5 General Electric Recent Developments
- 4.9 Enzo Biochem
- 4.9.1 Enzo Biochem Company Information
- 4.9.2 Enzo Biochem Business Overview
- 4.9.3 Enzo Biochem Non-Radioactive Nucleic Acid Labeling Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Enzo Biochem Non-Radioactive Nucleic Acid Labeling Product Portfolio
- 4.9.5 Enzo Biochem Recent Developments
- 4.10 Agilent Technologies
- 4.10.1 Agilent Technologies Company Information
- 4.10.2 Agilent Technologies Business Overview
- 4.10.3 Agilent Technologies Non-Radioactive Nucleic Acid Labeling Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Agilent Technologies Non-Radioactive Nucleic Acid Labeling Product Portfolio
- 4.10.5 Agilent Technologies Recent Developments
5 Global Non-Radioactive Nucleic Acid Labeling Market Scenario by Region
- 5.1 Global Non-Radioactive Nucleic Acid Labeling Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Non-Radioactive Nucleic Acid Labeling Sales by Region: 2021-2032
- 5.2.1 Global Non-Radioactive Nucleic Acid Labeling Sales by Region: 2021-2026
- 5.2.2 Global Non-Radioactive Nucleic Acid Labeling Sales by Region: 2027-2032
- 5.3 Global Non-Radioactive Nucleic Acid Labeling Revenue by Region: 2021-2032
- 5.3.1 Global Non-Radioactive Nucleic Acid Labeling Revenue by Region: 2021-2026
- 5.3.2 Global Non-Radioactive Nucleic Acid Labeling Revenue by Region: 2027-2032
- 5.4 North America Non-Radioactive Nucleic Acid Labeling Market Facts & Figures by Country
- 5.4.1 North America Non-Radioactive Nucleic Acid Labeling Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Non-Radioactive Nucleic Acid Labeling Sales by Country (2021-2032)
- 5.4.3 North America Non-Radioactive Nucleic Acid Labeling Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Non-Radioactive Nucleic Acid Labeling Market Facts & Figures by Country
- 5.5.1 Europe Non-Radioactive Nucleic Acid Labeling Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Non-Radioactive Nucleic Acid Labeling Sales by Country (2021-2032)
- 5.5.3 Europe Non-Radioactive Nucleic Acid Labeling Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Non-Radioactive Nucleic Acid Labeling Market Facts & Figures by Country
- 5.6.1 Asia Pacific Non-Radioactive Nucleic Acid Labeling Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Non-Radioactive Nucleic Acid Labeling Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Non-Radioactive Nucleic Acid Labeling Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Non-Radioactive Nucleic Acid Labeling Market Facts & Figures by Country
- 5.7.1 South America Non-Radioactive Nucleic Acid Labeling Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Non-Radioactive Nucleic Acid Labeling Sales by Country (2021-2032)
- 5.7.3 South America Non-Radioactive Nucleic Acid Labeling Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Non-Radioactive Nucleic Acid Labeling Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Non-Radioactive Nucleic Acid Labeling Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Non-Radioactive Nucleic Acid Labeling Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Non-Radioactive Nucleic Acid Labeling Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Non-Radioactive Nucleic Acid Labeling Sales by Type (2021-2032)
- 6.1.1 Global Non-Radioactive Nucleic Acid Labeling Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Non-Radioactive Nucleic Acid Labeling Sales Market Share by Type (2021-2032)
- 6.2 Global Non-Radioactive Nucleic Acid Labeling Revenue by Type (2021-2032)
- 6.2.1 Global Non-Radioactive Nucleic Acid Labeling Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Non-Radioactive Nucleic Acid Labeling Revenue Market Share by Type (2021-2032)
- 6.3 Global Non-Radioactive Nucleic Acid Labeling Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Non-Radioactive Nucleic Acid Labeling Sales by Application (2021-2032)
- 7.1.1 Global Non-Radioactive Nucleic Acid Labeling Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Non-Radioactive Nucleic Acid Labeling Sales Market Share by Application (2021-2032)
- 7.2 Global Non-Radioactive Nucleic Acid Labeling Revenue by Application (2021-2032)
- 7.2.1 Global Non-Radioactive Nucleic Acid Labeling Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Non-Radioactive Nucleic Acid Labeling Revenue Market Share by Application (2021-2032)
- 7.3 Global Non-Radioactive Nucleic Acid Labeling Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Non-Radioactive Nucleic Acid Labeling Value Chain Analysis
- 8.1.1 Non-Radioactive Nucleic Acid Labeling Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Non-Radioactive Nucleic Acid Labeling Production Mode & Process
- 8.2 Non-Radioactive Nucleic Acid Labeling Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Non-Radioactive Nucleic Acid Labeling Distributors
- 8.2.3 Non-Radioactive Nucleic Acid Labeling Customers
9 Global Non-Radioactive Nucleic Acid Labeling Analyzing Market Dynamics
- 9.1 Non-Radioactive Nucleic Acid Labeling Industry Trends
- 9.2 Non-Radioactive Nucleic Acid Labeling Industry Drivers
- 9.3 Non-Radioactive Nucleic Acid Labeling Industry Opportunities and Challenges
- 9.4 Non-Radioactive Nucleic Acid Labeling Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst